# Evoxac

NDC: 0713-0883
Generic name: cevimeline hydrochloride
Labeler / Manufacturer: Cosette Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20220901

FDA application: NDA020989

## Active ingredients

- CEVIMELINE HYDROCHLORIDE: 30 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0713-0883"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0713-0883
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dac32a9b-05b8-42c2-9a29-d885a9279456